Framingham Heart Study

Framingham Heart Study The Framingham Heart Study (FHS) is one of the world’s most informative and longest-running studies

The Framingham Heart Study (FHS) is one of the world's most regarded research studies, starting first with its work on heart disease and expanding to other chronic diseases such as stroke, cancer, osteoporosis, diabetes and Alzheimer's disease. With over 4,000 articles published in academic journals such as the New England Journal of Medicine, the Journal of the American Medical Association, Nature Genetics, Circulation and the Lancet, FHS now seeks to do more. Fueled by the extraordinary dedication of three generations of participants, Framingham’s expansion into genomics, transcriptomics, and proteomics coupled with on-going integration of state-of-the-art technology, reflects its continued pursuit of new and innovative research. FHS is credited with much of the earliest findings that smoking, high blood pressure, high cholesterol, obesity, and diabetes lead to heart disease. In coining the term "risk factor" in 1961, the study set the foundation for the field of preventive medicine. Today, the study remains a global epicenter for public health research, operating at the intersection of population research, omics, systems biology, and personalized medicine. The Framingham Heart Study is supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health and Boston University School of Medicine, under NIH award 75N92019D00031.

Happy Halloween from your friends at The Framingham Heart Study!
10/31/2025

Happy Halloween from your friends at The Framingham Heart Study!

Thank you to everyone who joined us in celebrating the 325th anniversary Framingham!
10/21/2025

Thank you to everyone who joined us in celebrating the 325th anniversary Framingham!

The Framingham Heart Study will be attending Framingham Fest!Details in post.We can’t wait to see you there!
09/17/2025

The Framingham Heart Study will be attending Framingham Fest!

Details in post.

We can’t wait to see you there!

07/16/2025

What if I told you high blood pressure was one of the biggest risk factors for Stroke?

Findings from the Framingham Heart Study from 1970 help explain the correlation.

05/30/2025

Does lower muscle mass lead to greater injury risk? Well let’s see if we can answer that question!

05/28/2025

Today we breakdown glucose and continuous glucose monitors. Explaining some of the recent findings and information uncovered by the Framingham Heart Study

We have officially concluded the in person portion of this exam cycle (September 2022 - April 2025) and we cannot thank ...
05/06/2025

We have officially concluded the in person portion of this exam cycle (September 2022 - April 2025) and we cannot thank you enough for making exam 4 such a success!

If you are interested in participating remotely, please reach out to our excellent recruitment team to schedule a televisit appointment anytime between now and June 30th 2025.

Our team is available to coordinate a time that works best for you, and we encourage you to get in touch as soon as possible to secure your preferred slot! - FHS Recruitment Team

Address

73 Mount Wayte Avenue Ste 2
Framingham, MA
01702

Opening Hours

Monday 9am - 3pm
Tuesday 9am - 3pm
Wednesday 9am - 3pm
Thursday 9am - 3pm
Friday 9am - 3pm

Telephone

+15088726562

Website

Alerts

Be the first to know and let us send you an email when Framingham Heart Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Framingham Heart Study:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

The Framingham Heart Study (FHS) is one of the world's most regarded research studies, starting first with its work on heart disease and expanding to other chronic diseases such as stroke, cancer, osteoporosis, diabetes and Alzheimer's disease. With over 3,700 articles published in academic journals such as the New England Journal of Medicine, the Journal of the American Medical Association, Nature Genetics, Circulation and the Lancet, FHS now seeks to do more. Fueled by the extraordinary dedication of three generations of participants, Framingham’s expansion into genomics, transcriptomics, and proteomics coupled with on-going integration of state-of-the-art technology, reflects its continued pursuit of new and innovative research. Framingham is credited with much of the earliest findings that smoking, high blood pressure, high cholesterol, obesity, and diabetes lead to heart disease. In coining the term "risk factor" in 1961, the study set the foundation for the field of preventive medicine. Today, the study remains a global epicenter for public health research, operating at the intersection of population research, omics, systems biology, and personalized medicine. The Framingham Heart Study is a project of Boston University and the National Heart Lung and Blood Institute.

The Framingham Heart Study is supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health and Boston University School of Medicine, under NIH award 75N92019D00031.